STOCK TITAN
  1. Home
  2. SEC Filings
  3. ALMR
  4. [Form 4] Alamar Biosciences, Inc. Insider Trading Activity

Alamar Biosciences: Qiming entities sell 280,458 shares

The reported per-share figures are weighted averages, with footnotes giving execution-price ranges for each referenced group.

Filing Impact
(Neutral)
Filing Sentiment

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment worksHow the balance works

Form Type
4

Rhea-AI Filing Summary

Alamar Biosciences, Inc. (ALMR) reports sales of 280,458 common shares by Qiming-affiliated entities on October 23 and October 26, 2026. The shares were held of record by Qiming Managing Directors Fund VI, L.P., Qiming Venture Partners VI, L.P., Qiming Venture Partners VIII Investments, LLC, and Qiming Venture Partners VIII-HC, L.P. Reported weighted-average prices were $29.35, $30.23, and $30.85 per share on October 23, and $30.52 and $31.07 per share on October 26. No Rule 10b5-1 plan is reported.

Insider Qiming Corporate GP VI, Ltd., Qiming Managing Directors Fund VI, L.P., Qiming Venture Partners VI, L.P., Qiming GP VIII, LLC, Qiming Venture Partners VIII Investments, LLC, Qiming GP VIII-HC, LLC, Qiming Venture Partners VIII-HC, L.P.
Role 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner
Sold 280,458 shs ($8.57M)
Type Security Shares Price Value
Sale Common Stock F8, F2 2,313 $30.52 $71K
Sale Common Stock F9, F2 2 $31.07 $62.14
Sale Common Stock F8, F5 86,008 $30.52 $2.62M
Sale Common Stock F9, F5 70 $31.07 $2K
Sale Common Stock F8, F6 20,069 $30.52 $613K
Sale Common Stock F9, F6 16 $31.07 $497.12
Sale Common Stock F8, F7 24,027 $30.52 $733K
Sale Common Stock F9, F7 19 $31.07 $590.33
Sale Common Stock F1, F2 107 $29.35 $3K
Sale Common Stock F3, F2 832 $30.23 $25K
Sale Common Stock F4, F2 1,646 $30.85 $51K
Sale Common Stock F1, F5 3,975 $29.35 $117K
Sale Common Stock F3, F5 30,921 $30.23 $935K
Sale Common Stock F4, F5 61,191 $30.85 $1.89M
Sale Common Stock F1, F6 928 $29.35 $27K
Sale Common Stock F3, F6 7,215 $30.23 $218K
Sale Common Stock F4, F6 14,277 $30.85 $440K
Sale Common Stock F1, F7 1,110 $29.35 $33K
Sale Common Stock F3, F7 8,638 $30.23 $261K
Sale Common Stock F4, F7 17,094 $30.85 $527K
Holdings After Transaction: Common Stock — 1,738,295 shares (Indirect, See footnote)
Footnotes (9)
  1. F1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.605 to $29.56, inclusive. The reporting person undertakes to provide to Alamar Biosciences, Inc., any security holder of Alamar Biosciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes (1), (3), (4), (8) and (9) to this Form 4
  2. F2. These shares are held of record by Qiming Managing Directors Fund VI, L.P. ("Qiming Managing Directors"). Qiming Corporate GP VI, Ltd. ("Qiming Corporate") serves as the general partner of Qiming Managing Directors and may be deemed to have voting and dispositive power over the shares held by Qiming Managing Directors. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
  3. F3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.62 to $30.61, inclusive.
  4. F4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.62 to $31.335, inclusive.
  5. F5. These shares are held of record by Qiming Venture Partners VI, L.P., ("Qiming Venture Partners VI"). Qiming Corporate, through one intermediary, serves as the indirect general partner of Qiming Venture Partners VI and may be deemed to have voting and dispositive power over the shares held by Qiming Venture Partners VI. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
  6. F6. These shares are held of record by Qiming Venture Partners VIII Investments, LLC ("QVP VIII LLC"). Qiming GP VIII, LLC, through two parallel intermediaries, serves as the indirect general partner of QVP VIII LLC and may be deemed to have voting and dispositive power over the shares held by QVP VIII LLC. Qiming GP VIII, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
  7. F7. These shares are held of record by Qiming Venture Partners VIII-HC, L.P. ("QVP VIII-HC"). Qiming GP VIII-HC, LLC serves as the general partner of QVP VIII-HC and may be deemed to have voting and dispositive power over the shares held by QVP VIII-HC. Qiming GP VIII-HC, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
  8. F8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.07 to $31.065, inclusive.
  9. F9. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.07 to $31.115, inclusive.
Shares sold 280,458 shares Reported transactions on October 23 and October 26, 2026
Weighted-average sale price $29.35 per share October 23, 2026
Weighted-average sale price $30.23 per share October 23, 2026
Weighted-average sale price $30.85 per share October 23, 2026
Weighted-average sale price $30.52 per share October 26, 2026
Weighted-average sale price $31.07 per share October 26, 2026
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
voting and dispositive power regulatory
"may be deemed to have voting and dispositive power over the shares held"
pecuniary interest financial
"except to the extent of its proportionate pecuniary interest therein."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ALMR shares did Qiming-affiliated entities sell?
Qiming-affiliated entities reported selling 280,458 ALMR common shares on October 23 and October 26, 2026. The shares were held of record by Qiming Managing Directors Fund VI, L.P., Qiming Venture Partners VI, L.P., Qiming Venture Partners VIII Investments, LLC, and Qiming Venture Partners VIII-HC, L.P. No Rule 10b5-1 plan is reported.

What prices did the ALMR share sales report?
The reported weighted-average prices were $29.35, $30.23, and $30.85 per share on October 23, and $30.52 and $31.07 per share on October 26, 2026. Footnotes state that the referenced shares were sold in multiple transactions within these ranges: $28.605 to $29.56, $29.62 to $30.61, $30.62 to $31.335, $30.07 to $31.065, and $31.07 to $31.115.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Available on EDGAR Accepted by SEC EDGAR
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Qiming Corporate GP VI, Ltd.
(Last)(First)(Middle)
C/O MAPLES CORPORATE SERVICES LIMITED
PO BOX 309
(Street)
UGLAND HOUSEGRAND CAYMANKY1-1104
(City)(State)(Zip)
CAYMAN ISLANDS
(Country)		2. Issuer Name and Ticker or Trading Symbol
Alamar Biosciences, Inc. [ ALMR ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
DirectorX10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
10/23/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
XForm filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock10/23/2026S107D$29.35(1)172,231ISee footnote(2)
Common Stock10/23/2026S832D$30.23(3)171,399ISee footnote(2)
Common Stock10/23/2026S1,646D$30.85(4)169,753ISee footnote(2)
Common Stock10/23/2026S3,975D$29.35(1)6,400,806ISee footnote(5)
Common Stock10/23/2026S30,921D$30.23(3)6,369,885ISee footnote(5)
Common Stock10/23/2026S61,191D$30.85(4)6,308,694ISee footnote(5)
Common Stock10/23/2026S928D$29.35(1)1,493,506ISee footnote(6)
Common Stock10/23/2026S7,215D$30.23(3)1,486,291ISee footnote(6)
Common Stock10/23/2026S14,277D$30.85(4)1,472,014ISee footnote(6)
Common Stock10/23/2026S1,110D$29.35(1)1,788,073ISee footnote(7)
Common Stock10/23/2026S8,638D$30.23(3)1,779,435ISee footnote(7)
Common Stock10/23/2026S17,094D$30.85(4)1,762,341ISee footnote(7)
Common Stock10/26/2026S2,313D$30.52(8)167,440ISee footnote(2)
Common Stock10/26/2026S2D$31.07(9)167,438ISee footnote(2)
Common Stock10/26/2026S86,008D$30.52(8)6,222,686ISee footnote(5)
Common Stock10/26/2026S70D$31.07(9)6,222,616ISee footnote(5)
Common Stock10/26/2026S20,069D$30.52(8)1,451,945ISee footnote(6)
Common Stock10/26/2026S16D$31.07(9)1,451,929ISee footnote(6)
Common Stock10/26/2026S24,027D$30.52(8)1,738,314ISee footnote(7)
Common Stock10/26/2026S19D$31.07(9)1,738,295ISee footnote(7)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
1. Name and Address of Reporting Person*
Qiming Corporate GP VI, Ltd.
(Last)(First)(Middle)
C/O MAPLES CORPORATE SERVICES LIMITED
PO BOX 309
(Street)
UGLAND HOUSEGRAND CAYMANKY1-1104
(City)(State)(Zip)
CAYMAN ISLANDS
(Country)
Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Qiming Managing Directors Fund VI, L.P.
(Last)(First)(Middle)
C/O MAPLES CORPORATE SERVICES LIMITED
PO BOX 309
(Street)
UGLAND HOUSEGRAND CAYMANKY1-1104
(City)(State)(Zip)
CAYMAN ISLANDS
(Country)
Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Qiming Venture Partners VI, L.P.
(Last)(First)(Middle)
C/O MAPLES CORPORATE SERVICES LIMITED
PO BOX 309
(Street)
UGLAND HOUSEGRAND CAYMANKY1-1104
(City)(State)(Zip)
CAYMAN ISLANDS
(Country)
Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Qiming GP VIII, LLC
(Last)(First)(Middle)
C/O MAPLES CORPORATE SERVICES LIMITED
PO BOX 309
(Street)
UGLAND HOUSEGRAND CAYMANKY1-1104
(City)(State)(Zip)
CAYMAN ISLANDS
(Country)
Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Qiming Venture Partners VIII Investments, LLC
(Last)(First)(Middle)
C/O MAPLES CORPORATE SERVICES LIMITED
PO BOX 309
(Street)
UGLAND HOUSEGRAND CAYMANKY1-1104
(City)(State)(Zip)
CAYMAN ISLANDS
(Country)
Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Qiming GP VIII-HC, LLC
(Last)(First)(Middle)
C/O MAPLES CORPORATE SERVICES LIMITED
PO BOX 309
(Street)
UGLAND HOUSEGRAND CAYMANKY1-1104
(City)(State)(Zip)
CAYMAN ISLANDS
(Country)
Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Qiming Venture Partners VIII-HC, L.P.
(Last)(First)(Middle)
C/O MAPLES CORPORATE SERVICES LIMITED
PO BOX 309
(Street)
UGLAND HOUSEGRAND CAYMANKY1-1104
(City)(State)(Zip)
CAYMAN ISLANDS
(Country)
Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
Explanation of Responses:
1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.605 to $29.56, inclusive. The reporting person undertakes to provide to Alamar Biosciences, Inc., any security holder of Alamar Biosciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes (1), (3), (4), (8) and (9) to this Form 4
2. These shares are held of record by Qiming Managing Directors Fund VI, L.P. ("Qiming Managing Directors"). Qiming Corporate GP VI, Ltd. ("Qiming Corporate") serves as the general partner of Qiming Managing Directors and may be deemed to have voting and dispositive power over the shares held by Qiming Managing Directors. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.62 to $30.61, inclusive.
4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.62 to $31.335, inclusive.
5. These shares are held of record by Qiming Venture Partners VI, L.P., ("Qiming Venture Partners VI"). Qiming Corporate, through one intermediary, serves as the indirect general partner of Qiming Venture Partners VI and may be deemed to have voting and dispositive power over the shares held by Qiming Venture Partners VI. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
6. These shares are held of record by Qiming Venture Partners VIII Investments, LLC ("QVP VIII LLC"). Qiming GP VIII, LLC, through two parallel intermediaries, serves as the indirect general partner of QVP VIII LLC and may be deemed to have voting and dispositive power over the shares held by QVP VIII LLC. Qiming GP VIII, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
7. These shares are held of record by Qiming Venture Partners VIII-HC, L.P. ("QVP VIII-HC"). Qiming GP VIII-HC, LLC serves as the general partner of QVP VIII-HC and may be deemed to have voting and dispositive power over the shares held by QVP VIII-HC. Qiming GP VIII-HC, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.07 to $31.065, inclusive.
9. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.07 to $31.115, inclusive.
Qiming GP VIII, LLC By: /s/ Ho Man LAM/Authorized Signatory10/27/2026
Qiming Venture Partners VIII Investments, LLC By: /s/ Ho Man LAM/Manager10/27/2026
Qiming GP VIII-HC, LLC By: /s/ Ho Man LAM/Authorized Signatory10/27/2026
Qiming Venture Partners VIII-HC, L.P. By: /s/ Ho Man LAM/Authorized Signatory10/27/2026
Qiming Corporate GP VI, Ltd By: /s/ Ho Man LAM/Authorized Signatory10/27/2026
Qiming Managing Directors Fund VI, L.P. By: /s/ Ho Man LAM/Authorized Signatory10/27/2026
Qiming Venture Partners VI, L.P. By: /s/ Ho Man LAM/Authorized Signatory10/27/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

Keep reading

More on ALMR

All ALMR news

Trending in the feed

SIMO
Silicon Motion Announces Results for the Quarterly Period Ended September 30, 2026 Open the live feed